Pons
PrivateLast Round
Accelerator
Sep 23, 2024
Total Funding Raised
$520,800
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pons is a healthcare technology company that develops device-agnostic AI software to improve ultrasound imaging by providing advanced visual insights and enhancing scan resolution, tissue contrast, and noise reduction through deep learning algorithms without the need for costly new hardware.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pons Comparables
Compare Pons with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioticsAI | 82% | |
| SmartAlpha | 80% | |
| Koios Medical | 78% | |
Pons Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 23, 2024 | ||||
| Grant | Aug 21, 2024 | ||||
| Grant | Jun 21, 2024 | ||||
| Seed | Dec 19, 2022 | ||||
| Accelerator | Nov 30, 2022 | ||||
Accelerator | Mar 1, 2022 |
Key People
Founding team and executive leadership
Pons Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AgeTech Collaborative | Grant |
| H7 BioCapital | Accelerator |
| Unlock Capital | Accelerator |
| SOSV | Seed, Accelerator |
| HAX | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 107% MoM, reaching 2.1K.
Pons Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pons's valuation, stock price, and market status.